Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ramoil Management Ltd ADVT

Advantis Corp is a development stage company. It is pursuing business opportunities to the development of pharmaceutical grade CBD extractions, concentrates and medicines in Nevada, California, and Washington. The company is also establishing partnerships with businesses that develop and sell proprietary consumer products and services. It is developing a product line for the consumer, music... see more

GREY:ADVT - Post Discussion

Ramoil Management Ltd > Cease Trade ordered!!! Just great...
View:
Post by 1001Spartans on Jul 31, 2019 3:18pm

Cease Trade ordered!!! Just great...

UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION

SECURITIES EXCHANGE ACT OF 1934
Release No. 86336 / July 9, 2019

The Securities and Exchange Commission ("Commission") announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the "Exchange Act"), of trading in the securities of Advantis Corporation ("ADVT") of Newport Beach, California at 9:30 a.m. EDT on July 10, 2019, and terminating at 11:59 p.m. EDT on July 23, 2019.

The Commission temporarily suspended trading in the securities of ADVT because of questions concerning the reliability of the information that, since at least April 2018, ADVT is providing to the public via disclosures on OTC Markets website, including, but not limited to, accounting compliance reports and attorney letters. The order was entered pursuant to Section 12(k) of the Exchange Act.

The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company.

Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not he has complied with the rule, he should not enter any quotation but immediately contact the staff in the Division of Trading and Markets, Office of Interpretation and Guidance, at (202) 551-5777. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering quotations relating to ADVT's securities until such time as he has familiarized himself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation which is in violation of the rule, the Commission will consider the need for prompt enforcement action.

If any broker-dealer or other person has any information which may relate to this matter, contact Michael Paley, Assistant Regional Director, New York Regional Office, at (212) 336-0145. The SEC appreciates the assistance of OTC Markets Group, Inc. and the Financial Industry Regulatory Authority.

Original

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities